Bridging News
Original Chinese Technology Benefits the World | Insights
Chongqing - "The Chongqing HIFU machine has played a crucial role in treating fibroids and pancreatic cancer and exploring the immunological effects of HIFU treatment," said Professor David Cranston, President of the International Society of Minimally Invasive and Virtual Surgery (ISMIVS).
He highlighted the significance of Chongqing's High-Intensity Focused Ultrasound (HIFU) machine during the 5th Yangtze International Summit of Minimally Invasive and Noninvasive Medicine & 2023 "The Belt and Road" Innovation Forum on Minimally Invasive and Noninvasive Medicine, which recently took place in Liangjiang New area of Chongqing.
Professor David Cranston, President of the International Society of Minimally Invasive and Virtual Surgery (ISMIVS). (Photo/Wang Yiling)
The summit brought together over 120 overseas medical experts and more than 500 professionals in minimally invasive and noninvasive medicine. The aim was to discuss cutting-edge technologies, exchange ideas, and promote global medicine development.
Advancing collaborative innovation in minimally invasive medicine with Chongqing
During the summit, Professor Cranston emphasized the importance of collaboration and protecting intellectual property rights. He cited successful collaborations between Oxford University and Chongqing Medical University, where discussions were held to safeguard intellectual property rights. Senior representatives from both institutions took part in these discussions to ensure the protection of their respective rights.
Chongqing Medical University has been committed to the innovative development of ultrasound technology. Its independently developed HIFU tumor treatment system, known as Haifu Knife®, is China's first large-scale medical device with completely independent intellectual property rights. It has conducted the world's largest multicenter clinical research on ultrasound ablation of uterine fibroids.
Professor Cranston reiterated the longstanding collaboration between Oxford University and Chongqing Haifu Medical Technology Co. Ltd. in advancing minimally invasive and noninvasive medicine. Significant progress has been made through joint efforts.
The international summit provided an opportunity to review the achievements and developments in this field. It also fostered valuable collaboration and knowledge exchange among attendees from different countries.
This year, Chongqing Medical University established the Future Technology College of Minimally Invasive Medicine. Its goal is to build a global highland for talent cultivation and technological innovation in the field of minimally invasive medicine.
Over 240000 patients and 30 countries and regions benefitted from HIFU
As medical experts continue to prioritize patient care and explore innovative solutions, the field of minimally invasive and noninvasive medicine is set to make significant contributions to global healthcare.
Rudy Leon De Wilde, Director and Past-President of the European Society of Gynecological Endoscopy (ESGE). (Photo/Rudy Leon De Wilde)
Rudy Leon De Wilde, Director and Past-President of the European Society of Gynecological Endoscopy (ESGE), underscored the importance of transcending regional boundaries and considering global solutions in minimally invasive and noninvasive medicine.
Professor Wilde emphasized the necessity for alternative therapies in cases where surgical intervention may not be feasible or preferred by patients. "In our global context, we need to be receptive to a wide range of therapeutic approaches to provide optimal patient care—this is our ultimate goal," added Professor Wilde.
Lee Chyilong, Chairman of the Board of Trustees of the Asian-Pacific Association of Gynecologic Endoscopy and Minimally Invasive Therapy (APAGE) lauded the widespread implementation of HIFU therapy across various regions, including Africa, the Middle East, and Europe. Expressing confidence in the ongoing promotion of innovative medical concepts and devices, Professor Lee believed this would significantly contribute to the progression of the Belt and Road Initiative.
Lee Chyilong, Chairman of Board of Trustees, Asian-Pacific Association of Gynecologic Endoscopy and Minimally Invasive Therapy (APAGE). (Photo/Wang Yiling)
China's original HIFU system has led to the establishment of 50 minimally invasive and noninvasive treatment centers across 22 countries and regions along the Belt and Road. This expansion represents a new era of minimally invasive and noninvasive treatments, with the HIFU system securing a third of the global market share for high-intensity focused ultrasound tumor treatment equipment.
The appeal of minimally invasive and noninvasive treatment technologies, especially ultrasound therapy, has garnered global attention. As of the close of 2022, the HIFU system has treated over 240,000 patients worldwide suffering from various benign and malignant tumors. The technology has been exported to 30 countries and regions and obtained access permits in 46 countries and regions, further amplifying its global footprint.
Related Stories